JPMorgan analyst Lisa Gill raised the firm’s price target on Privia Health (PRVA) to $28 from $27 and keeps an Overweight rating on the shares. The analyst updated the company’s model.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRVA: